...
首页> 外文期刊>Human and Experimental Toxicology >In vivo protection studies of bis-quaternary 2-(hydroxyimino)- N -(pyridin-3-yl) acetamide derivatives (HNK oximes) against tabun and soman poisoning in Swiss albino mice
【24h】

In vivo protection studies of bis-quaternary 2-(hydroxyimino)- N -(pyridin-3-yl) acetamide derivatives (HNK oximes) against tabun and soman poisoning in Swiss albino mice

机译:在瑞士白化小鼠中对BIS-QUATERNARA 2-(羟基咪啶) - N - (吡啶-3-基)乙酰胺衍生物(HNK肟)的体内保护研究

获取原文
获取原文并翻译 | 示例
           

摘要

The study reports antidotal efficacy of three HNK [ bis quaternary 2-(hydroxyimino)-N-(pyridin-3yl) acetamide derivatives] and pralidoxime (2-PAM), against soman and tabun poisoning in Swiss albino mice. Protection index (PI) was determined (treatment doses: HNK oximes, ×0.20 of their median lethal dose (LD 50 ) and 2-PAM, 30 mg/kg, intramuscularly (im)) together with atropine (10 mg/kg, intraperitoneally). Probit log doses with difference of 0.301 log of LD 50 of the nerve agents administered and inhibition of acetylcholinesterase (AChE) activity by 50% (IC 50 ) was calculated at optimized time in brain and serum. Using various doses of tabun and soman (subcutaneously (sc)), in multiples of their IC 50 , AChE reactivation ability of the oximes was studied. Besides, acute toxicity (0.8× LD 50 , im, 24 h postexposure) of HNK-102 and 2-PAM was also compared by determining biochemical, hematological variables and making histopathological observations. Protection offered by HNK-102 against tabun poisoning was found to be four times higher compared to 2-PAM. However, nearly equal protection was noted with all the four oximes against soman poisoning. HNK-102 reactivated brain AChE activity by 1.5 times more than 2-PAM at IC 50 dose of soman and tabun. Acute toxicity studies of HNK-102 and 2-PAM showed sporadic changes in urea, uric acid, aspartate aminotransferase, and so on compared to control group, however, not supported by histopathological investigations. The present investigation showed superiority of newly synthesized HNK-102 oxime over standard 2-PAM, as a better antidote, against acute poisoning of tabun (4.00 times) and soman (1.04 times), in Swiss albino mice.
机译:该研究报告了三个HNK [双季氨基)-N-(吡啶-3-(吡啶-3)乙酰胺衍生物]和Proaloxime(2-PAM)的抗病毒疗效,对瑞士白化小鼠的索曼和塔甲中毒。测定保护指数(PI)(治疗剂量:HNK肟,其中位数致死剂量(LD 50)和2-PAM,30mg / kg,肌内(IM))的与阿托品(10mg / kg,腹膜内的2-20) )。在脑和血清的优化时间计算施用和抑制乙酰胆碱酯酶(IC 50)的神经试剂的0.30 LD 50的LD 50的LD 50的差异差异的探测日志剂量。在其IC 50的倍数中,使用各种剂量的Tabun和Soman(皮下(SC)),研究了肟的ache再活化能力。此外,还通过确定生物化学,血液变量和制备组织病理学观察,比较HNK-102和2-PAM的急性毒性(0.8×LD 50,IM,24小时,24小时后,24小时,24小时,24小时,24小时后)。与2-PAM相比,HNK-102对Tabun中毒的保护提供了4倍。然而,对索曼中毒的所有四个肟都注意到了几乎相同的保护。 HNK-102重新激活的脑疼痛活动在IC 50剂量的索马和禁忌处超过2-PAM的1.5倍。 HNK-102和2-PAM的急性毒性研究表明尿素,尿酸,天冬氨酸氨基转移酶的散发变化,但与对照组相比,组织病理学研究不支持。目前的调查显示出新合成的HNK-102肟在标准2-PAM上的优势,作为更好的解毒剂,反对Tabun的急性中毒(4.00次)和Soman(1.04次),在瑞士白化小鼠中。

著录项

  • 来源
    《Human and Experimental Toxicology》 |2017年第12期|共16页
  • 作者单位

    Pharmacology and Toxicology Division Defence Research &

    Development Establishment Gwalior Madhya;

    Pharmacology and Toxicology Division Defence Research &

    Development Establishment Gwalior Madhya;

    Pharmacology and Toxicology Division Defence Research &

    Development Establishment Gwalior Madhya;

    Pharmacology and Toxicology Division Defence Research &

    Development Establishment Gwalior Madhya;

    Process Technology Development Division Defence Research &

    Development Establishment Gwalior;

    Process Technology Development Division Defence Research &

    Development Establishment Gwalior;

    Pharmacology and Toxicology Division Defence Research &

    Development Establishment Gwalior Madhya;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 毒物学(毒理学);
  • 关键词

    HNK oximes; soman; tabun; HNK-102; in vivoAChE IC50;

    机译:HNK肟;索曼;Tabun;HNK-102;在Viofache IC50;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号